Teladoc and Livongo merge into $37 billion remote-health company as coronavirus keeps patients home

Telehealth has been one of the massive growth stories of the Covid-19 era, as patients avoid clinics and hospitals where they risk exposure to the coronavirus. The Teladoc-Livongo deal is the third-largest in the U.S. this year.